147 |
Evidence-Based Medicine Analysis of Current DES Clinical |
Gregg W. Stone |
Jul. 01. 05 |
146 |
Renal Stenting ASPIRE II, Update on Resist |
Krishna Rocha-Singh |
Jul. 01. 05 |
145 |
Peripheral Vascular Interventions |
Gerald Dorros |
Jul. 01. 05 |
144 |
Pathology of Vulnerable Plaque |
Renu Virmani |
Jun. 16. 05 |
143 |
Virtual Histology - A Technical and Clinical Update |
Gary S. Mintz |
Jun. 16. 05 |
142 |
The Biolimus A9 DES Program (Focus on Stealth 1) |
Eberhard Grube |
Jun. 10. 05 |
141 |
The Endeavor DES Program (Focus on Endeavor 2) |
Richard E. Kuntz |
Jun. 10. 05 |
140 |
Recent Updates from the Cypher Trials (Cypher Meta-Analysis, Diabetes, Late FU from FIM and SIRIUS, ARTS II) |
Alexandre Abizaid |
Jun. 03. 05 |
139 |
Recent Updates from the Taxus Trials (Taxus 2 and 4 Late FU, Taxus Meta-Analysis, and Taxus 5) |
Gregg W. Stone |
Jun. 03. 05 |
138 |
DES Pathobiology Considerations: What We Know and What We Don't Know Can Hurt Us! |
Renu Virmani |
May. 27. 05 |